The roots and aerial parts of Chelidonium majus L. were extracted with EtOH and fractionated using CHCl3 and EtOH. Repeated column chromatography, preparative TLC and crystallization led to the isolation of five isoquinoline alkaloids, stylopine (3), chelidonine (4), homochelidonine (5), protopine (6), and allocryptopine (7), along with two isolation artifacts 6-ethoxydihydrosanguinarine (1) and 6-ethoxydihydrochelerythrine (2). All isolated compounds were tested for human blood acetylcholinesterase (HuAChE) and human plasma butyrylcholinesterase (HuBuChE) inhibitory activity. The isolation artifacts exhibited the highest activity against HuAChE and HuBuChE with IC50 values of 0.83 ± 0.04 μM and 4.20 ± 0.19 μM for 6-ethoxydihydrochelerythrine and 3.25 ± 0.24 μM and 4.51 ± 0.31 μM for 6-ethoxydihydrosanguinarine. The most active of the naturally-occurring alkaloids was chelidonine, which inhibited both HuAChE and HuBuChE in a dose-dependent manner with IC50 values of 26.8 ± 1.2 μM and 31.9 ± 1.4 μM, respectively.
LahiriDK, FarlowMR, GreigNH, SambamurtiK. (2002)Current drug targets for Alzheimer's disease treatment. Drug Development Research, 56267-281.
2.
RahmanAU, CoudharyMI. (2001)Bioactive natural products as a potential source of new pharmacophores a theory of memory. Pure and Applied Chemistry, 73555-560.
3.
GreigNH, LahiriDK, SambamurtiK. (2002)Butyrylcholinesterase: an important new target in Alzheimer's disease therapy. International Psychogeriatrics, 1477-91.
4.
LleóA. (2007)Current therapeutic options for Alzheimer's disease. Current Genomics, 8550-558.
5.
RecanatiniM, ValentiP. (2004)Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeutics. Current Pharmaceutical Design, 103157-3166.
6.
BerkovS, BastidaJ, NikolovaM, ViladomatF, CodinaC. (2008)Rapid TLC/GC-MS identification of acetylcholinesterase inhibitors in alkaloid extracts. Phytochemical Analysis, 19411-419.
7.
HostettmannK, BorlozA, UrbainA, MarstonA. (2006)Natural product inhibitors of acetylcholinesterase. Current Organic Chemistry, 10825-847
8.
ColomboML, BosisioE. (1996) Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacological Research, 33127-134.
9.
ToméF, ColomboML (1995) Alkaloids from Chelidonium majus: distribution in the plants and factors affecting their accumulation. Phytochemistry, 4037-39.
10.
SlavíkJ, SlavíkováL. (1977) Minor alkaloids from Chelidonium majus L. Collection of Czechoslovak Chemical Communications, 422686-2693.
11.
CohenHG, SeifenEE, StraubKD, TiefnbackC, StermitzFR. (1978)Structural specifity of the NaK-ATPase inhibition by sanquinarine, an isoquinoline benzophenanthridine alkaloid. Biochemical Pharmacology, 272555-2558.
12.
LenfeldJ, KroutilM, MarsalekE, SlavikJ, PreiningerV, SimanekV. (1981) Antiinflamantory activity of quaternary benzophenanthridine alkaloids from Chelidonium majus. Planta Medica, 43161-165.
13.
ChoKM, YooID, KimWG(2006)8-Hydroxydihydrochelerythrine and 8-hydroxydihydrosanquinarine with a potent acetylcholinesterase inhibitory activity from Chelidonium majus L. Biological and Pharmaceutical Bulletin, 292317-2320.
WeinguangZ, WenzaoL, GuoshiT. (1987) Chemical study of alkaloids from Corydalis bungeana. Planta Medica, 53418-420.
16.
TakaoN, KamiguachiM, IwasaK, MoritaN, KuriyamaK. (1984)Stereochemistry of hydrobenzo[c]phenanthridine alkaloids. Optical properties and absolute configuration of (+)-14-epicoridine, (+)-corydine, (+)-chelidonine and releated compounds. Archiv der Pharmazie, 317223-237.
17.
ToušekJ, DommisseR, DostálJ, ŽákZ, PietersL, MarekR. (2002)Configuration and conformation of sanguinarine and chelerythrine free bases stereoisomers. Journal of Molecular Structure, 613102-113.
18.
MarekR, SečkářováP, HulováD, MarekJ, DostálJ Sklenář (2003)Palmatine and berberine isolation artifacts. Journal of Natural Products, 66481-486.
19.
DostálJ, TáborskáE, SlavíkJ. (1995)Structure of chelerythrine base. Journal of Natural Products, 58723-729.
20.
DostálJ, MarekR, SlavíkJ, TáborskáE, PotáčekM, SklenářV. (1998)Sanguinarine pseudobase: re-examination of NMR assigments using gradient-enhanced spectroscopy. Magnetic Resonance in Chemistry, 36869-872.
EllmanGL, CourtneyKD, AndresV, FeatherstoneRM. (1961)A new rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 788-95.
23.
WhiteleyCG, DayaS. (1995) Protein ligand interactions. Part 5: Isoquinoline alkaloids as inhibitors of acetylcholinesterase from Electrophorus electricus. Journal of Enzyme Inhibition, 9285-294.
24.
KhoranaN, MarkmeeS, IngkaninanK, RuchirawatS, KitbunnadajR, PullagurlaMR. (2009)Evaluation of new lead for acetylcholinesterase inhibition. Medicinal Chemistry Research, 18231-241.
25.
KuznetsovaLP, Nikol'skayaEB, SochilinaEE, FaddeevaMD. (2002)Inhibition of human blood acetylcholinesterase and butyrylcholinesterase by some alkaloids. Journal of Evolutionary Biochemistry and Physiology, 3835-39.
26.
UlrichováJ, WalterováD, PreiningerV, SlavíkJ, LenfeldJ, CushmanM, ŠimánekV. (1983)Inhibition of acetylcholinesterase activity by some isoquinoline alkaloids. Planta Medica, 48111-115.
27.
SteckTL, KantJA. (1974)Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods in Enzymology31 (Pt A), 172-180.
